Showing page 612 of 1181 pages of list content

  1. Anticancer pan-ErbB inhibitors reduce inflammation and tissue injury and exert broad-spectrum antiviral effects

    This article has 34 authors:
    1. Sirle Saul
    2. Marwah Karim
    3. Luca Ghita
    4. Pei-Tzu Huang
    5. Winston Chiu
    6. Verónica Durán
    7. Chieh-Wen Lo
    8. Sathish Kumar
    9. Nishank Bhalla
    10. Pieter Leyssen
    11. Farhang Alem
    12. Niloufar A. Boghdeh
    13. Do H.N. Tran
    14. Courtney A. Cohen
    15. Jacquelyn A. Brown
    16. Kathleen E. Huie
    17. Courtney Tindle
    18. Mamdouh Sibai
    19. Chengjin Ye
    20. Ahmed Magdy Khalil
    21. Kevin Chiem
    22. Luis Martinez-Sobrido
    23. John M. Dye
    24. Benjamin A. Pinsky
    25. Pradipta Ghosh
    26. Soumita Das
    27. David E. Solow-Cordero
    28. Jing Jin
    29. John P. Wikswo
    30. Dirk Jochmans
    31. Johan Neyts
    32. Steven De Jonghe
    33. Aarthi Narayanan
    34. Shirit Einav

    Reviewed by ScreenIT

    This article has 1 evaluationAppears in 1 listLatest version Latest activity
  2. Broad neutralization against SARS-CoV-2 variants induced by a modified B.1.351 protein-based COVID-19 vaccine candidate

    This article has 21 authors:
    1. Danmei Su
    2. Xinglin Li
    3. Cui He
    4. Xueqing Huang
    5. Meilin Chen
    6. Qiang Wang
    7. Wenchang Qin
    8. Ying Liang
    9. Rong Xu
    10. Jinhua Wu
    11. Peiwen Luo
    12. Xiaofang Yang
    13. Yilan Zeng
    14. Mei Luo
    15. Dongxia Luo
    16. David M Salisbury
    17. Donna Ambrosino
    18. George Siber
    19. Ralf Clemens
    20. Peng Liang
    21. Joshua G. Liang

    Reviewed by ScreenIT

    This article has 1 evaluationAppears in 1 listLatest version Latest activity
  3. Distinct immune responses in patients infected with influenza or SARS-CoV-2, and in COVID-19 survivors, characterised by transcriptomic and cellular abundance differences in blood

    This article has 20 authors:
    1. Jelmer Legebeke
    2. Jenny Lord
    3. Rebekah Penrice-Randal
    4. Andres F. Vallejo
    5. Stephen Poole
    6. Nathan J. Brendish
    7. Xiaofeng Dong
    8. Catherine Hartley
    9. John W. Holloway
    10. Jane S. Lucas
    11. Anthony P. Williams
    12. Gabrielle Wheway
    13. Fabio Strazzeri
    14. Aaron Gardner
    15. James P.R. Schofield
    16. Paul J. Skipp
    17. Julian A. Hiscox
    18. Marta E. Polak
    19. Tristan W. Clark
    20. Diana Baralle

    Reviewed by ScreenIT

    This article has 1 evaluationAppears in 1 listLatest version Latest activity
  4. Effects of common mutations in the SARS-CoV-2 Spike RBD and its ligand, the human ACE2 receptor on binding affinity and kinetics

    This article has 6 authors:
    1. Michael I Barton
    2. Stuart A MacGowan
    3. Mikhail A Kutuzov
    4. Omer Dushek
    5. Geoffrey John Barton
    6. P Anton van der Merwe
    This article has been curated by 1 group:
    • Curated by eLife

      Evaluation Summary:

      This manuscript is of interest to virologists working on SARS-CoV-2, as well as biochemists and biophysicists who perform binding experiments with surface plasmon resonance (SPR), as it provides detailed affinity and kinetics analysis of the effect of mutations in variants of concern in the SARS-CoV-2 receptor binding domain with receptor ACE2 and two 'common' mutations in ACE2.

      (This preprint has been reviewed by eLife. We include the public reviews from the reviewers here; the authors also receive private feedback with suggested changes to the manuscript. Reviewer #1 agreed to share their name with the authors.)

    Reviewed by eLife, ScreenIT

    This article has 6 evaluationsAppears in 2 listsLatest version Latest activity